Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed method for unsaturated nitriles using boronic acids. High yield, scalable process for pharma intermediates. Cost-effective supply chain solution.
Patent CN102491994B details a novel preparation method for phosphocholine alkyl ester ensuring high purity and simplified purification for reliable pharmaceutical intermediates supply chain efficiency.
Patent CN103265616B details a stable N(2)-Ala-Gln synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102775345A reveals a novel route for Roflumilast intermediates, offering high purity and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN103102324A details a novel Leucogen synthesis eliminating methyl ester impurities. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Discover the patented synthesis of 2-(2-thienyl) ethanol p-toluenesulfonate. A robust, high-yield route for pharmaceutical intermediates ensuring supply chain stability.
Patent CN109305977B reveals a safer double-oxidation route for Tazobactam. Enhance supply chain stability and reduce manufacturing risks with this novel process.
Patent CN102603552A details a green iodide-catalyzed route for alpha-keto amides. Discover cost-effective, room-temperature synthesis for reliable pharmaceutical intermediate supply.
Patent CN101501000B details a novel purification process for Montelukast using chiral amine salts, offering high optical purity and cost reduction in pharmaceutical intermediate manufacturing without chromatography.
Novel palladium-catalyzed route reduces costs and improves purity for Telmisartan manufacturing supply chain stability and commercial scalability for global buyers.
Novel route for Gemcitabine HCl with high yield and purity. Reduces steps and improves scalability for API manufacturing.
Patent CN1671669A details a high-purity celecoxib synthesis route reducing regioisomers via controlled water and acid catalysis for cost-effective manufacturing.
Patent CN115745836A reveals a blue-light mediated method for C-C bond cleavage, offering cost-effective routes for high-purity pharmaceutical intermediates and functional materials.
Novel catalyst-free synthesis of dithiophosphonates offers green chemistry benefits and supply chain reliability for pharmaceutical intermediate manufacturing partners globally.
Advanced patent CN107033210A details a high-yield Fulvestrant route. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN1671669A details a high-purity celecoxib synthesis method reducing regioisomers via controlled water and acid catalysis for cost-effective manufacturing.
Patent CN108101830B details a metal-free oxidation route for oxindoles, offering cost reduction in API manufacturing and high-purity intermediates.
Patent CN107573276A reveals NHC-catalyzed indolinone synthesis. High yield, mild conditions offer cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel mild preparation of antineoplastic drug tegafur using 2-benzoyloxy tetrahydrofuran. High yield, >99.7% purity, scalable industrial process.
Patent CN117924403B details a low-toxicity synthesis route for sodium carbenoxolone using toluene and DMAP, ensuring high purity and cost efficiency for pharmaceutical supply chains.